Rossari BiotechNSE:ROSSARI -0.43%87 PEG Ratio is 1.27 as of Jul. 06, 2026, which is 5% below its 10-year median of 1.33. GuruFocus rates NSE:ROSSARI with a GF Score™ of 87/100 and a GF Value™ of ₹1,002.05 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 612 Chemicals companies, Rossari Biotech ranks better than 67.81% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Rossari Biotech's PEG Ratio or its related term are showing as below:
NSE:ROSSARI'
s PEG Ratio Range Over the Past 10 Years
Min: 0.93 Med: 1.33 Max: 1.67
Current: 1.27
During the past 9 years, Rossari Biotech's highest PEG Ratio was 1.67. The lowest was 0.93. And the median was 1.33.
NSE:ROSSARI's PEG Ratio is ranked better than 67.81% of 612
companies
in the Chemicals industry
Industry Median: 2.29
vs NSE:ROSSARI: 1.27
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Rossari Biotech (NSE:ROSSARI) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Rossari Biotech PEG Ratio Related Terms
Rossari Biotech PEG Ratio Historical Data
* Premium members only.
The historical data trend for Rossari Biotech's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ROSSARI vs LIN, SHW, ECL: PEG Ratio Comparison
For the Specialty Chemicals subindustry, Rossari Biotech's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rossari Biotech PEG Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Rossari Biotech's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Rossari Biotech's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Rossari Biotech (NSE:ROSSARI) has a PEG Ratio of 1.27 as of Jul. 06, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Rossari Biotech and its competitors. This is near median its historical median of 1.33. Over the past decade, Rossari Biotech's PEG Ratio has ranged from 0.93 to 1.67. According to the industry distribution chart, Rossari Biotech ranks #197 out of 612 companies in the Chemicals industry, placing it in the top 32.2%.
Is Rossari Biotech's PEG Ratio too high?
Rossari Biotech's current PEG Ratio of 1.27 is near median its 10-year median of 1.33. Over the past 10 years, this metric has ranged from a low of 0.93 to a high of 1.67. The Chemicals industry median PEG Ratio is 2.29. Rossari Biotech's value of 1.27 is 44.5% below this industry median. Based on the distribution chart, Rossari Biotech ranks #197 out of 612 companies in the Chemicals industry, which is above the industry midpoint. Overall, Rossari Biotech has a GF Score™ of 87/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rossari Biotech's PEG Ratio compare to LIN and SHW?
According to the Chemicals industry distribution chart, Rossari Biotech ranks #197 out of 612 companies for PEG Ratio. This puts Rossari Biotech in the upper half of its industry. The industry median PEG Ratio is 2.29. Rossari Biotech's value of 1.27 is 44.5% below this benchmark. Historically, Rossari Biotech's own PEG Ratio has ranged from 0.93 to 1.67 over the past decade. While the company's 10-year median is 1.33 vs. the industry median of 2.29, Rossari Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Chemicals company?
The median PEG Ratio among Chemicals companies is 2.29, based on 612 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rossari Biotech's current PEG Ratio of 1.27 is 44.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Rossari Biotech and its competitors. For the Chemicals industry, the median PEG Ratio is 2.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rossari Biotech's current PEG Ratio is 1.27, which is near median its own 10-year median of 1.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossari Biotech stock overvalued right now?
Based on GuruFocus' analysis, Rossari Biotech (NSE:ROSSARI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹1,002.05, compared to a current price of ₹521.65 — trading 47.9% below its estimated fair value. The current PEG Ratio is 1.27, which is near median its 10-year median of 1.33 and 44.5% below the Chemicals industry median of 2.29. Rossari Biotech's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Rossari Biotech (NSE:ROSSARI), the current PEG Ratio is 1.27 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rossari Biotech (NSE:ROSSARI) Overvalued in 2026?
Based on GuruFocus' analysis, Rossari Biotech stock appears to be undervalued.
The current stock price of ₹521.65 is trading 47.9% below its estimated GF Value™ of ₹1,002.05.
GuruFocus considers Rossari Biotech to be Possible Value Trap.
Key valuation signals for NSE:ROSSARI:
PEG Ratio: 1.27 (near median its 10-year median of 1.33)
GF Value™: ₹1,002.05 vs. price of ₹521.65 (47.9% below fair value)
Industry Position: 44.5% below the Chemicals median (#197 of 612)
No single metric tells the full story. See the NSE:ROSSARI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rossari Biotech Ltd is a specialty chemical manufacturing company. It provides customized solutions to specific industrial and production requirements of its customers in the FMCG, apparel, poultry, and animal feed industries through its product portfolio comprising home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its business is organized into three categories: home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its products include soaps and detergents, paints, inks and coatings, ceramics and tiles, water treatment chemicals, pulp and paper, and cleaning chemical formulations, among others. The company generates the majority revenue from India.
87GF Score
Get the complete analysis for NSE:ROSSARI
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ROSSARI has been successfully added to your 
